Status:
COMPLETED
The Evaluation of Cellular and Humoral Immunity to COVID-19 in Moscow Residents
Lead Sponsor:
Moscow Department of Health
Collaborating Sponsors:
Clinical City Hospital named after I.V. Davydovsky of Moscow Department of Healthcare
Moscow State University of Medicine and Dentistry
Conditions:
Covid19
Respiratory Viral Infection
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the research is to estimate the levels of cellular and humoral immunity to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among Moscow residents over 18 years old. During ...
Eligibility Criteria
Inclusion
- residents of the Moscow city (registered in Moscow);
- 18 years old or above;
- signed informed consent.
Exclusion
- citizenship of a foreign state;
- refusal to sign the informed consent.
Key Trial Info
Start Date :
October 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
5340 Patients enrolled
Trial Details
Trial ID
NCT04898140
Start Date
October 20 2020
End Date
December 31 2021
Last Update
September 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical City Hospital named after I.V. Davydovsky of Moscow Department of Healthcare
Moscow, Russia